Evidence map›Paper›PMID 42188297›Full record

ArticleMarine drugs2026

Development of HPMC-Based Hard Capsules with Rapid Disintegration Across Simulated Gastrointestinal pH Conditions: Formulation Design, Process Optimization, and Disintegration Mechanism of the HPMC/GG/ι-C Ternary System.

Yuting Dong, Songlin Ye, Xiaojun Hong, Yafang Shi, Youcheng Liu, Xueqin Zhang, Jing Ye, Meitian Xiao

Abstract read
In one paragraph

Article in Marine drugs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuting DongCollege of Chemical Engineering, Huaqiao University, Xiamen 361021, China.
Songlin YeAnhui Huangshan Capsule Co., Ltd., Xuancheng 242600, China.
Xiaojun HongFujian Green Power Biotechnology Co., Ltd., Zhangzhou 363100, China.
Yafang ShiInstrumental Analysis Center of Huaqiao University, Xiamen 361021, China.
Youcheng LiuAnhui Huangshan Capsule Co., Ltd., Xuancheng 242600, China.
Xueqin ZhangCollege of Chemical Engineering, Huaqiao University, Xiamen 361021, China.
Jing YeCollege of Chemical Engineering, Huaqiao University, Xiamen 361021, China.
Meitian XiaoCollege of Chemical Engineering, Huaqiao University, Xiamen 361021, China.

Funding

Fujian Fisheries Research Institute FJHYF-L-2025-29Fujian Provincial Department of Science and Technology 2024Y4007National Natural Science Foundation of China 22078120Xiamen Municipal Bureau of Science and Technology 3502Z20251001
6 · The paper itself

Abstract

While hydroxypropyl methylcellulose (HPMC) is a promising plant-based alternative to gelatin, its industrial application is limited by poor mechanical properties and high production costs. In this study, high-performance HPMC-based hard capsules were developed using an HPMC/gellan gum/ι-carrageenan ternary system. The formulation and preparation process were optimized via single-factor experiments, response surface methodology, and low-field nuclear magnetic resonance analysis. Scanning electron microscopy was applied to characterize the microstructural evolution during disintegration. The optimized capsules exhibited rapid disintegration within 15 min across four pH media and satisfied the requirements of the Chinese Pharmacopoeia (2025). Drug dissolution profiles using cefradine and ranitidine hydrochloride showed over 85% cumulative release within 30 min, with similarity factors higher than 50 relative to commercial gelatin capsules under the tested conditions. This work provides a feasible and low-cost strategy for the industrial production of plant-based capsules and promotes the high-value utilization of polysaccharide-based capsule materials.

Indexed as

CarrageenanHypromellose DerivativesPolysaccharides, BacterialCapsulesChemistry, PharmaceuticalDrug CompoundingDrug LiberationHydrogen-Ion ConcentrationSolubilityCapsulesCarrageenangellan gumHypromellose DerivativesPolysaccharides, Bacterialgellan gumhard capsuleshydroxypropyl methylcelluloseι-carrageenan

Identifiers

PMID42188297
PMCPMC13208135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.